We are monitoring the impact of COVID-19 & Recession alarm on Atopic Dermatitis Market Get in touch with us for detailed analysis Know More

✖

Know More

✖

  1. Home
  2. >
  3. Healthcare
  4. >
  5. Atopic Dermatitis Market
Share on

Global Atopic Dermatitis Market Size, Share, Trends, COVID-19 Impact & Growth Analysis Report - Segmented By Treatment Type (Drug Treatment and Radiation Treatment), Route Of Administration (Topical and Oral), Distribution Channel & Region - Industry Forecast (2022 to 2027)

Published: January, 2022
ID: 5169
Pages: 175

Atopic Dermatitis Market Size (2022 to 2027)

As per our report, the global atopic dermatitis market size was valued at USD 11.77 billion in 2022. It is expected to grow at a CAGR of 13.13% and be worth USD 21.80 billion by 2027. Therefore, the market is expected to progress at a modest pace through the forecast period.

Atopic Dermatitis is an inflammatory skin disease, and the degree of its severity varies from patient to patient. It usually begins in childhood and is mainly confined to the flexural surfaces of the body. It is highly prevalent and is more commonly known as eczema. Itching, redness of the skin, cracking, weeping, etc., are symptoms, and it is a long-term disease. Low humidity, cold weather, and seasonal allergies are the common causes of it, and the pattern of the disease and its severity determine the kind of treatment it ought to receive.

MARKET DRIVERS:

Y-O-Y growth in the incidence of atopic dermatitis, the launch of biologics & small molecules, premium-priced drugs substituting generic first-line and second-line therapeutics, and improved diagnostics are expected to stoke the growth of the global atopic dermatitis market.

Growing incidences of skin allergies and chronic disorders elevate the market's growth rate to the extent. Atopic dermatitis disease severity ranges from patient to patient, and the treatment procedures involve the severity degree. Escalating expenditure on healthcare and the growing popularity of these treatment procedures through digital advertisements accelerates the growth rate of the global atopic dermatitis market. 

Additionally, a growing number of initiatives from various governments in improving the infrastructure of hospitals and clinics with the latest equipment are expected to expand the growth scope for the global atopic dermatitis market. Furthermore, an increasing number of patients suffering from various skin disorders, changes in climatic conditions, and the rise in disposable income in both developed and developing countries are further expected to accelerate the market's growth rate. Besides, the emergence of the latest technologies in the medical sector and the introduction of innovative procedures magnify this market's growth. 

MAJOR CHALLENGES:

Rising complications and side effects after the treatment procedure in some people hinder the demand of the global atopic dermatitis market.

The shortage of skilled people in hospitals and clinics and fluctuations in the economic strategies negatively impact the growth rate of the atopic dermatitis market. In addition, less availability of necessary equipment in rural areas remains a challenging factor for the market players. Also, the high cost of the treatment procedures due to advanced features is declining the growth rate of this market.

Impact of COVID-19 on the global atopic dermatitis market:

The sudden outburst of the new coronavirus (COVID-19) was caused by the severe acute respiratory syndrome SARS-CoV-2 reagent. The pandemic crisis has affected every industry in terms of profit or production. Atopic dermatitis doesn't affect critical markers' regularity in patients hospitalized with coronavirus. Adults with atopic diseases are at significant risk of lower respiratory tract infections (LRTIs) and Upper respiratory tract infections (URTIs) than those without atopic diseases. Patients infected with coronavirus didn't face any difficulties during their infection course. Moreover, patients with atopic dermatitis are said to have an efficient and safe therapy with dupilumab. During the COVID-19 pandemic period, the market teledermatology has increased due to a drop in the frequent clinical visits because of sanitary restrictions. Most of the patients with Atopic Dermatitis (AD) continue their generalized treatment, and patients should not stop their oral and biological therapy or other existing treatments without consulting their physicians. As per the National Eczema Association, the coronavirus (COVID-19) pandemic crisis doesn't increase the threat of life-threatening issues in people with eczema. On the other hand, people with atopic dermatitis have higher incidences of anxiety and depression, and patients are found to account for increased occurrences in the emergency department. All these factors are expected to accelerate the growth rate of the global atopic dermatitis market during the forecast period.

REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2021 to 2027

Base Year

2021

Forecast Period

2022 to 2027

Segments Covered

By Treatment Type, Route of Administration, Distribution channel, and Region.

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, APAC, Latin America, Middle East & Africa

 

This market research report on the global atopic dermatitis market has been segmented and sub-segmented into the following categories and analyzed market size and forecast until 2026.

Atopic Dermatitis Market - By Treatment Type:

  • Drug Treatment
  • Radiation Treatment

Based on treatment type, the drug treatment segment holds the highest market share with the rise in the prevalence of early diagnosis diseases. In addition, investments in research and development institutes to improve healthcare centers' services bolstered the market's growth rate. 

Atopic Dermatitis Market - By Route of Administration:

  • Topical
  • Oral

Based on the administration route, the topical segment leads with a dominant market share, whereas the oral segment will have the highest CAGR in the coming years. Support from public and private organizations over managing all the operations in the hospitals and clinics only to provide effective treatment procedures is expanding the market share.

Atopic Dermatitis Market - By Distribution Channel:

Based on the distribution channel, the hospital pharmacies segment is ruling with the highest market share due to the increasing scale of hospitals and clinics worldwide. The growing flow of patients to hospitals fuels the demand for the global Atopic Dermatitis Market. 

Atopic Dermatitis Market – By Region:

  • North America
    • The United States
    • Canada
    • Rest of North America
  • Europe
    • United Kingdom
    • Spain
    • Germany
    • Italy
    • France
    • Rest of Europe
  • Asia Pacific
    • India
    • Japan
    • China
    • Australia
    • Singapore
    • Malaysia
    • South Korea
    • New Zealand
    • Southeast Asia
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of LATAM
  • The Middle East and Africa

Geographically, the North American atopic dermatitis market is expected to be the market leader in the global atopic dermatitis treatment market during the forecast period. New product launches, early treatment adoption, and lifestyle changes are the reasons behind it.

Globally, the European atopic dermatitis market is predicted to be the second-largest regional market between 2020 to 2025. Heavy investment in R&D activities in this region is the cause of the observable trend mentioned above. As a result, some European countries like Spain and the United Kingdom are expected to showcase promising growth from 2020 to 2025.

The Asia Pacific atopic dermatitis market is predicted to be the fastest-growing global atopic dermatitis treatment market in the aforementioned forecast period. Japan is forecasted to register the highest CAGR during the same period. This extension of the region can be attributed to victims' significant unmet clinical needs, increasing spending on healthcare, and adequate treatment availability.

The Latin American atopic dermatitis market is expected to grow significantly in the next five years due to a rapidly growing population, changing lifestyles, and a paradigm shift towards western lifestyles; increasing R&D and a large target patient pool are attributable to the observable trend mentioned above.

The MEA atopic dermatitis market is anticipated to undergo sluggish growth in the aforementioned forecast period.

KEY MARKET PARTICIPANTS:

Some of the notable companies operating in the global atopic dermatitis market profiled in this report are Astellas Pharma Inc., Valeant Pharmaceuticals International, Inc., Sanofi S.A., Anacor Pharmaceuticals, Inc.., Meda Pharmaceuticals, Regeneron Pharmaceuticals Inc., Novartis International AG, and Pfizer Inc.

RECENT MARKET DEVELOPMENTS:

  • Crisborole, a non-steroidal topical anti-inflammatory, is developed by Anacor Pharmaceuticals, which has significant use for various skin diseases in adults. 
  • Dupilumab is another drug approved to treat severe atopic dermatitis treatment. 

1. Introduction        

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods 

                1.4 General Study Assumptions                

2. Research Methodology                  

                2.1 Introduction      

                2.2 Research Phases                      

       2.2.1 Secondary Research           

       2.2.2 Primary Research 

       2.2.3 Econometric Modelling      

       2.2.4 Expert Validation  

                2.3 Analysis Design

                2.4 Study Timeline 

3. Overview              

                3.1 Executive Summary                

                3.2 Key Inferences

                3.3 Epidemiology     

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)           

                4.1 Market Drivers 

                4.2 Market Restraints                    

                4.3 Key Challenges

                4.4 Current Opportunities in the Market     

5. Market Segmentation                     

                5.1 Treatment Type                       

       5.1.1 Introduction           

       5.1.2 Drug Treatment    

                       5.1.2.1 Emollients

                       5.1.2.2 Antihistamines

                       5.1.2.3 Antibiotics

                       5.1.2.4 Corticosteroids

                       5.1.2.5 Calcineurin Inhibitors

       5.1.3 Radiation Treatment           

       5.1.4 Y-o-Y Growth Analysis, By Treatment Type               

       5.1.5 Market Attractiveness Analysis, By Treatment Type             

       5.1.6 Market Share Analysis, By Treatment Type              

                5.2 Route of administration                        

       5.2.1 Introduction           

       5.2.2 Topical      

       5.2.3 Oral            

       5.2.4 Y-o-Y Growth Analysis, By Route of administration               

       5.2.5 Market Attractiveness Analysis, By Route of administration             

       5.2.6 Market Share Analysis, By Route of administration               

                5.3 Distribution Channel      

       5.3.1 Introduction           

       5.3.2 Hospital Pharmacies            

       5.3.3 Retail Pharmacies 

       5.3.4 Online Pharmacies               

       5.3.5 Y-o-Y Growth Analysis, By Distribution Channel      

       5.3.6 Market Attractiveness Analysis, By Distribution Channel    

       5.3.7 Market Share Analysis, By Distribution Channel      

6. Geographical Analysis                     

                6.1 Introduction      

      6.1.1 Regional Trends    

      6.1.2 Impact Analysis     

      6.1.3 Y-o-Y Growth Analysis        

                       6.1.3.1 By Geographical Area

                       6.1.3.2 By Treatment Type

                       6.1.3.3 By Route of administration

                       6.1.3.4 By Distribution Channel

     6.1.4  Market Attractiveness Analysis     

                       6.1.4.1 By Geographical Area

                       6.1.4.2 By Treatment Type

                       6.1.4.3 By Route of administration

                       6.1.4.4 By Distribution Channel

       6.1.5  Market Share Analysis      

                       6.1.5.1 By Geographical Area

                       6.1.5.2 By Treatment Type

                       6.1.5.3 By Route of administration

                       6.1.5.4 By Distribution Channel

                6.2 North America

       6.2.1 Introduction           

       6.2.2 United States         

       6.2.3 Canada     

                6.3 Europe                         

       6.3.1 Introduction           

       6.3.2 U.K             

       6.3.3 Spain         

       6.3.4 Germany 

       6.3.5 Italy            

       6.3.6 France       

                6.4 Asia-Pacific                 

       6.4.1 Introduction           

       6.4.2 China         

       6.4.3 India          

       6.4.4 Japan         

       6.4.5 Australia   

       6.4.6 South Korea           

                6.5 Latin America    

       6.5.1 Introduction           

       6.5.2 Brazil          

       6.5.3 Argentina

       6.5.4 Mexico     

       6.5.5 Rest of Latin America          

                6.6 Middle East & Africa      

       6.6.1 Introduction           

       6.6.2 Middle-East            

       6.6.3 Africa         

7. Strategic Analysis              

                7.1 PESTLE analysis

       7.1.1 Political     

       7.1.2 Economic 

       7.1.3 Social         

       7.1.4 Technological         

       7.1.5 Legal          

       7.1.6 Environmental       

                7.2 Porter’s Five analysis     

       7.2.1 Bargaining Power of Suppliers        

       7.2.2 Bargaining Power of Consumers    

       7.2.3 Threat of New Entrants     

       7.2.4 Threat of Substitute Products and Services              

       7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis               

                8.1 Astellas Pharma Inc.      

       8.1.1 Overview 

       8.1.2 Product Analysis   

       8.1.3 Financial analysis  

       8.1.4 Recent Developments       

       8.1.5 SWOT analysis       

       8.1.6 Analyst View          

                8.2 Sanofi S.A.                  

                8.3 Valeant Pharmaceuticals International, Inc.                 

                8.4 Novartis International AG                    

                8.5 Pfizer Inc.                    

                8.6 Meda Pharmaceuticals 

                8.7 Regeneron Pharmaceuticals Inc.                       

                8.8 Anacor Pharmaceuticals, Inc.     

9. Competitive Landscape                  

                9.1 Market share analysis   

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, Collaborations, and Joint Ventures

                9.4 New Product Launches

10. Market Outlook and Investment Opportunities                

Appendix                  

                a) List of Tables                

                b) List of Figures     

  1. Global Atopic Dermatitis Market, By Region, From 2022 to 2027 (USD Billion)
  2. Global Atopic Dermatitis Market, By Treatment Type, From 2022 to 2027 (USD Billion)
  3. Global Drug Treatment Market, By Region, From 2022 to 2027 (USD Billion)
  4. Global Radiation Treatment Market, By Region, From 2022 to 2027 (USD Billion)
  5. Global Atopic Dermatitis Market, By Route of Administration, From 2022 to 2027 (USD Billion)
  6. Global Topical Market, By Region, From 2022 to 2027 (USD Billion)
  7. Global Oral Market, By Region, From 2022 to 2027 (USD Billion)
  8. Global Atopic Dermatitis Market, By Distribution Channel, From 2022 to 2027 (USD Billion)
  9. Global Hospital Pharmacies Market, By Region, From 2022 to 2027 (USD Billion)
  10. Global Retail Pharmacies Market, By Region, From 2022 to 2027 (USD Billion)
  11. Global Online Pharmacies Market, By Region, From 2022 to 2027 (USD Billion)
  12. North America Atopic Dermatitis Market, By Treatment Type, From 2022 to 2027 (USD Billion)
  13. North America Drug Treatment Market, By Region, From 2022 to 2027 (USD Billion)
  14. North America Radiation Treatment Market, By Region, From 2022 to 2027 (USD Billion)
  15. North America Atopic Dermatitis Market, By Route of Administration, From 2022 to 2027 (USD Billion)
  16. North America Topical Market, By Region, From 2022 to 2027 (USD Billion)
  17. North America Oral Market, By Region, From 2022 to 2027 (USD Billion)
  18. North America Atopic Dermatitis Market, By Distribution Channel, From 2022 to 2027 (USD Billion)
  19. North America Hospital Pharmacies Market, By Region, From 2022 to 2027 (USD Billion)
  20. North America Retail Pharmacies Market, By Region, From 2022 to 2027 (USD Billion)
  21. North America Online Pharmacies Market, By Region, From 2022 to 2027 (USD Billion)
  22. United States Atopic Dermatitis Market, By Treatment Type, From 2022 to 2027 (USD Billion)
  23. United States Atopic Dermatitis Market, By Route of Administration, From 2022 to 2027 (USD Billion)
  24. United States Atopic Dermatitis Market, By Distribution Channel, From 2022 to 2027 (USD Billion)
  25. Canada Atopic Dermatitis Market, By Treatment Type, From 2022 to 2027 (USD Billion)
  26. Canada Atopic Dermatitis Market, By Route of Administration, From 2022 to 2027 (USD Billion)
  27. Canada Atopic Dermatitis Market, By Distribution Channel, From 2022 to 2027 (USD Billion)
  28. Europe Atopic Dermatitis Market, By Treatment Type, From 2022 to 2027 (USD Billion)
  29. Europe Drug Treatment Market, By Region, From 2022 to 2027 (USD Billion)
  30. Europe Radiation Treatment Market, By Region, From 2022 to 2027 (USD Billion)
  31. Europe Atopic Dermatitis Market, By Route of Administration, From 2022 to 2027 (USD Billion)
  32. Europe Topical Market, By Region, From 2022 to 2027 (USD Billion)
  33. Europe Oral Market, By Region, From 2022 to 2027 (USD Billion)
  34. Europe Atopic Dermatitis Market, By Distribution Channel, From 2022 to 2027 (USD Billion)
  35. Europe Hospital Pharmacies Market, By Region, From 2022 to 2027 (USD Billion)
  36. Europe Retail Pharmacies Market, By Region, From 2022 to 2027 (USD Billion)
  37. Europe Online Pharmacies Market, By Region, From 2022 to 2027 (USD Billion)
  38. U.K. Atopic Dermatitis Market, By Treatment Type, From 2022 to 2027 (USD Billion)
  39. U.K. Atopic Dermatitis Market, By Route of Administration, From 2022 to 2027 (USD Billion)
  40. U.K. Atopic Dermatitis Market, By Distribution Channel, From 2022 to 2027 (USD Billion)
  41. Germany Atopic Dermatitis Market, By Treatment Type, From 2022 to 2027 (USD Billion)
  42. Germany Atopic Dermatitis Market, By Route of Administration, From 2022 to 2027 (USD Billion)
  43. Germany Atopic Dermatitis Market, By Distribution Channel, From 2022 to 2027 (USD Billion)
  44. France Atopic Dermatitis Market, By Treatment Type, From 2022 to 2027 (USD Billion)
  45. France Atopic Dermatitis Market, By Route of Administration, From 2022 to 2027 (USD Billion)
  46. France Atopic Dermatitis Market, By Distribution Channel, From 2022 to 2027 (USD Billion)
  47. Italy Atopic Dermatitis Market, By Treatment Type, From 2022 to 2027 (USD Billion)
  48. Italy Atopic Dermatitis Market, By Route of Administration, From 2022 to 2027 (USD Billion)
  49. Italy Atopic Dermatitis Market, By Distribution Channel, From 2022 to 2027 (USD Billion)
  50. Spain Atopic Dermatitis Market, By Treatment Type, From 2022 to 2027 (USD Billion)
  51. Spain Atopic Dermatitis Market, By Route of Administration, From 2022 to 2027 (USD Billion)
  52. Spain Atopic Dermatitis Market, By Distribution Channel, From 2022 to 2027 (USD Billion)
  53. Asia Pacific Atopic Dermatitis Market, By Treatment Type, From 2022 to 2027 (USD Billion)
  54. Asia Pacific Drug Treatment Market, By Region, From 2022 to 2027 (USD Billion)
  55. Asia Pacific Radiation Treatment Market, By Region, From 2022 to 2027 (USD Billion)
  56. Asia Pacific Atopic Dermatitis Market, By Route of Administration, From 2022 to 2027 (USD Billion)
  57. Asia Pacific Topical Market, By Region, From 2022 to 2027 (USD Billion)
  58. Asia Pacific Oral Market, By Region, From 2022 to 2027 (USD Billion)
  59. Asia Pacific Atopic Dermatitis Market, By Distribution Channel, From 2022 to 2027 (USD Billion)
  60. Asia Pacific Hospital Pharmacies Market, By Region, From 2022 to 2027 (USD Billion)
  61. Asia Pacific Retail Pharmacies Market, By Region, From 2022 to 2027 (USD Billion)
  62. Asia Pacific Online Pharmacies Market, By Region, From 2022 to 2027 (USD Billion)
  63. Japan Atopic Dermatitis Market, By Treatment Type, From 2022 to 2027 (USD Billion)
  64. Japan Atopic Dermatitis Market, By Route of Administration, From 2022 to 2027 (USD Billion)
  65. Japan Atopic Dermatitis Market, By Distribution Channel, From 2022 to 2027 (USD Billion)
  66. China Atopic Dermatitis Market, By Treatment Type, From 2022 to 2027 (USD Billion)
  67. China Atopic Dermatitis Market, By Route of Administration, From 2022 to 2027 (USD Billion)
  68. China Atopic Dermatitis Market, By Distribution Channel, From 2022 to 2027 (USD Billion)
  69. India Atopic Dermatitis Market, By Treatment Type, From 2022 to 2027 (USD Billion)
  70. India Atopic Dermatitis Market, By Route of Administration, From 2022 to 2027 (USD Billion)
  71. India Atopic Dermatitis Market, By Distribution Channel, From 2022 to 2027 (USD Billion)
  72. Australia Atopic Dermatitis Market, By Treatment Type, From 2022 to 2027 (USD Billion)
  73. Australia Atopic Dermatitis Market, By Route of Administration, From 2022 to 2027 (USD Billion)
  74. Australia Atopic Dermatitis Market, By Distribution Channel, From 2022 to 2027 (USD Billion)
  75. South Korea Atopic Dermatitis Market, By Treatment Type, From 2022 to 2027 (USD Billion)
  76. South Korea Atopic Dermatitis Market, By Route of Administration, From 2022 to 2027 (USD Billion)
  77. South Korea Atopic Dermatitis Market, By Distribution Channel, From 2022 to 2027 (USD Billion)
  78. Latin America Atopic Dermatitis Market, By Treatment Type, From 2022 to 2027 (USD Billion)
  79. Latin America Drug Treatment Market, By Region, From 2022 to 2027 (USD Billion)
  80. Latin America Radiation Treatment Market, By Region, From 2022 to 2027 (USD Billion)
  81. Latin America Atopic Dermatitis Market, By Route of Administration, From 2022 to 2027 (USD Billion)
  82. Latin America Topical Market, By Region, From 2022 to 2027 (USD Billion)
  83. Latin America Oral Market, By Region, From 2022 to 2027 (USD Billion)
  84. Latin America Atopic Dermatitis Market, By Distribution Channel, From 2022 to 2027 (USD Billion)
  85. Latin America Hospital Pharmacies Market, By Region, From 2022 to 2027 (USD Billion)
  86. Latin America Retail Pharmacies Market, By Region, From 2022 to 2027 (USD Billion)
  87. Latin America Online Pharmacies Market, By Region, From 2022 to 2027 (USD Billion)
  88. Brazil Atopic Dermatitis Market, By Treatment Type, From 2022 to 2027 (USD Billion)
  89. Brazil Atopic Dermatitis Market, By Route of Administration, From 2022 to 2027 (USD Billion)
  90. Brazil Atopic Dermatitis Market, By Distribution Channel, From 2022 to 2027 (USD Billion)
  91. Argentina Atopic Dermatitis Market, By Treatment Type, From 2022 to 2027 (USD Billion)
  92. Argentina Atopic Dermatitis Market, By Route of Administration, From 2022 to 2027 (USD Billion)
  93. Argentina Atopic Dermatitis Market, By Distribution Channel, From 2022 to 2027 (USD Billion)
  94. Mexico Atopic Dermatitis Market, By Treatment Type, From 2022 to 2027 (USD Billion)
  95. Mexico Atopic Dermatitis Market, By Route of Administration, From 2022 to 2027 (USD Billion)
  96. Mexico Atopic Dermatitis Market, By Distribution Channel, From 2022 to 2027 (USD Billion)
  97. Rest of Latin America Atopic Dermatitis Market, By Treatment Type, From 2022 to 2027 (USD Billion)
  98. Rest of Latin America Atopic Dermatitis Market, By Route of Administration, From 2022 to 2027 (USD Billion)
  99. Rest of Latin America Atopic Dermatitis Market, By Distribution Channel, From 2022 to 2027 (USD Billion)
  100. Middle East and Africa Atopic Dermatitis Market, By Treatment Type, From 2022 to 2027 (USD Billion)
  101. Middle East and Africa Drug Treatment Market, By Region, From 2022 to 2027 (USD Billion)
  102. Middle East and Africa Radiation Treatment Market, By Region, From 2022 to 2027 (USD Billion)
  103. Middle East and Africa Atopic Dermatitis Market, By Route of Administration, From 2022 to 2027 (USD Billion)
  104. Middle East and Africa Topical Market, By Region, From 2022 to 2027 (USD Billion)
  105. Middle East and Africa Oral Market, By Region, From 2022 to 2027 (USD Billion)
  106. Middle East and Africa Atopic Dermatitis Market, By Distribution Channel, From 2022 to 2027 (USD Billion)
  107. Middle East and Africa Hospital Pharmacies Market, By Region, From 2022 to 2027 (USD Billion)
  108. Middle East and Africa Retail Pharmacies Market, By Region, From 2022 to 2027 (USD Billion)
  109. Middle East and Africa Online Pharmacies Market, By Region, From 2022 to 2027 (USD Billion)
  110. Middle East Atopic Dermatitis Market, By Treatment Type, From 2022 to 2027 (USD Billion)
  111. Middle East Atopic Dermatitis Market, By Route of Administration, From 2022 to 2027 (USD Billion)
  112. Middle East Atopic Dermatitis Market, By Distribution Channel, From 2022 to 2027 (USD Billion)
  113. Africa Atopic Dermatitis Market, By Treatment Type, From 2022 to 2027 (USD Billion)
  114. Africa Atopic Dermatitis Market, By Route of Administration, From 2022 to 2027 (USD Billion)
  115. Africa Atopic Dermatitis Market, By Distribution Channel, From 2022 to 2027 (USD Billion)
↻

Please wait. . . . Your request is being processed

FAQ's

How big is the atopic dermatitis market?

As per our research report, the global atopic dermatitis market size was valued at USD 11.77 billion in 2022 and is estimated to grow by USD 21.8 billion by 2027.

Which segment by treatment type held the dominant share in the atopic dermatitis market in 2021?

Based on the treatment type, the drug type accounted for the major share of the global atopic dermatitis market in 2021.

Which geographical region led the atopic dermatitis market in 2021?

Among all the regions, the North American region was the leader in the global atopic dermatitis market in 2021.

Who are key players in the global atopic dermatitis market?

Astellas Pharma Inc., Valeant Pharmaceuticals International, Inc., Sanofi S.A., Anacor Pharmaceuticals, Inc.., Meda Pharmaceuticals, Regeneron Pharmaceuticals Inc., Novartis International AG, and Pfizer Inc. are a few of the noteworthy companies in the global atopic dermatitis market.

PURCHASE OPTIONS
pdf
$

4255

pdf excel
$

5060

pdf excel powerbi
$

7360

excel
$

2500

What You Get :

  • ✔ PDF Report Format.
  • ✔ Can be accessible by 1 single user.
  • ✔ 6 Months of Free Analyst Support.
  • ✔ PDF and Excel Datasheet Formats.
  • ✔ Can be accessible upto 2 to 5 users.
  • ✔ 1 Year of Free Analyst Support.
  • ✔ PDF, Excel and Power BI Dashboard.
  • ✔ Can be accessible by unlimited users.
  • ✔ 1 Year of Free Analyst Support.
  • ✔ Excel Datasheet Format.
  • ✔ Customized access as per user request.
  • ✔ Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 4255

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Research Areas

Reports By Region
Reports By Industry
Click for Request Sample